These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 4007782)

  • 1. Hyperprolactinaemia and testosterone production. Observations in 2 men on long-term dialysis.
    Stegmayr B; Skogström K
    Horm Res; 1985; 21(4):224-8. PubMed ID: 4007782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone levels after bromocriptine treatment in patients undergoing long-term hemodialysis.
    Vircburger MI; Prelević GM; Perić LA; Knezević J; Djukanović L
    J Androl; 1985; 6(2):113-6. PubMed ID: 3921506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis.
    Muir JW; Besser GM; Edwards CR; Rees LH; Cattell WR; Ackrill P; Baker LR
    Clin Nephrol; 1983 Dec; 20(6):308-14. PubMed ID: 6357576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prolactin suppression on hypogonadism im patients on maintenance haemodialysis.
    Tharandt L; Graben N; Schäfer R; Plewa G; Joachim K; Siegel R; Benker G; Reinwein D
    Proc Eur Dial Transplant Assoc; 1980; 17():323-7. PubMed ID: 6787583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogonadism, hyperprolactinaemia, and temporal lobe epilepsy in hyposexual men.
    Spark RF; Wills CA; Royal H
    Lancet; 1984 Feb; 1(8374):413-7. PubMed ID: 6142149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prolactin (PRL), testosterone (T), dehydroepiandrosterone (D) and dehydroepiandrosterone sulphate (D-s) in male uraemic patients on maintenance haemodialysis: effect of bromocriptine.
    Szücs J; Makó J; Györgyi T; Földes J; Fehér T
    Horm Metab Res; 1984 Sep; 16(9):503-4. PubMed ID: 6238895
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of long term dialysis therapy on blood prolactin patients with chronic renal failure].
    Pachelski J; Kokot F; Grzeszczak W
    Pol Tyg Lek; 1989 Feb; 44(9):214-6. PubMed ID: 2813182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bromocryptine in oligozoospermic men with hyperprolactinaemia.
    Krause W
    Reproduccion; 1980; 4(3):241-6. PubMed ID: 6780394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin in chronic renal failure, haemodialysis, and transplant patients.
    Peces R; Casado S; Frutos M; Horcajada C; López-Novoa JM; Hernando L
    Proc Eur Dial Transplant Assoc; 1979; 16():700-2. PubMed ID: 121462
    [No Abstract]   [Full Text] [Related]  

  • 10. Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin.
    Schaefer RM; Kokot F; Kuerner B; Zech M; Heidland A
    Int J Artif Organs; 1989 Jul; 12(7):445-9. PubMed ID: 2767790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pituitary-testicular evaluation in patients with chronic renal insufficiency in hemodialysis treatment].
    Coppola A; Cuomo G
    Minerva Med; 1990 Jun; 81(6):461-4. PubMed ID: 2113639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parlodel treatment of uremic hypogonadism in men.
    Ermolenko VM; Kukhtevich AV; Dedov II; Bunatian AF; Melnichenko GA; Gitel EP
    Nephron; 1986; 42(1):19-22. PubMed ID: 3079888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin-secreting tumors and hypogonadism in men.
    N Engl J Med; 1979 Mar; 300(10):563-4. PubMed ID: 763260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum prolactin, testosterone, dehydroepiandrosterone and dehydroepiandrosterone sulphate levels in chronic uremic patients treated by hemodialysis].
    Szücs J; Makó J; Fehér T; Györgyi T; Szathmári M
    Orv Hetil; 1984 Jul; 125(31):1865-8. PubMed ID: 6236413
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gonadal dysfunction in the male with chronic renal insufficiency].
    Joven J; Villabona C; Espinel E
    Med Clin (Barc); 1986 Feb; 86(6):249-53. PubMed ID: 3084891
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of dopaminergic mechanisms on 24-hour secretory patterns of prolactin, luteinizing hormone and testosterone in recumbent men.
    Sowers JR; Viosca SP; Windsor C; Korenman SG
    J Endocrinol Invest; 1983 Feb; 6(1):9-15. PubMed ID: 6841919
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prolactin and prostatic cancer. Modification of testosterone serum levels in estrogen-induced hyperprolactinemia by bromocriptine].
    Maganto E; Mayayo T; Mateos JA; Verdú F; Escudero Barrilero A
    Actas Urol Esp; 1983; 7(4):289-94. PubMed ID: 6624577
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypothalamo-hypophyseo-gonadal axis in individuals with chronic renal insufficiency subjected to hemodialysis].
    Mendoza C; Carreras A; Ruiz E; Ortega E; Hervás J; Osorio C
    Rev Esp Fisiol; 1985 Dec; 41(4):443-6. PubMed ID: 3938041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sexuality changes in a hemodialysis patient with hyperprolactinemia: therapeutic possibilities].
    Mondaini F; Gavazzi M; Benelli R; De Maio P
    Riv Ital Ginecol; 1980; 59 Suppl():93-6. PubMed ID: 6813937
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolactin and testosterone: independent circulating levels in hyperprolactinemic and normoprolactinemic amenorrhea. The effect of prolactin suppression by bromocriptine.
    Seppälä M; Hirvonen E; Unnérus HA; Ranta T; Laatikainen T
    J Clin Endocrinol Metab; 1976 Jul; 43(1):198-200. PubMed ID: 947938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.